PEREIRA, Rayssa Mayara de Oliveira.
Resumen:
The term Atypical Squamous Cells of Undetermined Significance (CEASI) was introduced by the Bethesda System in 1988, spawning several discussions about the abuse of this diagnosis and the most appropriate clinical approach to be followed. Although this term was only deployed in Bethesda System, various cytological classification systems have been proposed from numerical classification of Papanicolaou in 1941, in order to detect cancer precursor lesions of the cervix. And this diversity of terminology used in cervical smear results have caused some conflicts, resulting in different perceptions to the clinical significance of these classifications used. This study aimed to review the literature in order to determine the frequency of CEASI, found by the authors of the papers, and identifies the different classifications of diagnostic cytopathology Cervical used in the studies in the literature. During the review were found in the databases LILACS and SciELO, articles that supported the theme comprehensively and clearly, published from 2003 to 2013, including a period of 10 years.The term CEASI were the most frequent cytological finding of 64.2% (9/14) articles and content on this finding, in 13% (2/14) of the articles showed higher than estimated by the Ministry of Health (5%) and 13% (2/14) exceeds three times the diagnosis of low grade squamous intraepithelial lesions. Of the seven articles analyzed, only two were using the official nomenclature, a work made use of more than one classification, and only three subcategorizou the term CEASI. The data obtained show that this term remains very controversial land where there is still a lot of subjectivity, and that there is still resistance by pathologists in the use of official nomenclature in cytological reports. Quality control measures must be implemented by laboratories to minimize this problem and greater efforts should be employed to stimulate the use of the official nomenclature. It is noteworthy that the communication between the pro ¬ fessional clinicians and pathologists when needed is an important aspect of quality assurance in preventing cervical cancer.
